In addition, the TCGA dataset presented by the Human Protein Atlas indicates that OGT upregulation is associated with poorer patient outcomes in all stages of ccRCC as well as in stage I patients alone [35,41]. This evidence concerns the gene OGT and nonpapillary renal cell carcinoma.